Pharmaceutical ProductCached Profile

ELLIPSYS

Active Ingredients (Generic):Unmapped
Therapeutic Area: Catheters
LIFETIME PROMOTIONAL SPEND
$7,164,061
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

FDA Patient Safety Profile

Dynamic safety indicators compiled from official FDA product labels.

Active Clinical Trials

Clinical studies listing this drug as an active intervention.

Top Funded Physicians (Cumulative)

Doctors receiving the highest aggregate promotional support for this product.

Dr. JEFFREY HULLMedical Doctor$955,559
Dr. STEPHEN PARKERMedical Doctor$941,831
Dr. DALE YOUNGMedical Doctor$797,741
Dr. DAVID SMIDMedical Doctor$600,997
Dr. MARK DE BLOISMedical Doctor$341,491

Drug Marketing Payments Log

Federal registry records of promotional speaking, consulting, meals, and offsets.

Year:
2024
2024
2023
2022
2021

Querying Open Payments Database

Fetching live CMS.gov records for ELLIPSYS...